MMRGlobal Discloses $17MM Pipeline From MMRPro in Filing of

MMRGlobal Discloses $17MM Pipeline From MMRPro in Filing of Third
Quarter Results 
LOS ANGELES, CA -- (Marketwire) -- 11/15/12 --  MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR") today announced that as reported in yesterday's
quarterly filing on Form 10-Q for the period ended September 30,
2012, a minimum performance purchase Agreement was signed with
VisiInc PLC ("Visi") for the sale of MMRPro systems. The VISI MMRPro
bundle was launched to a network of hundreds of Value Added Resellers
("VARs") in Las Vegas this week. Additional presentations were made
at the Verizon/Alcatel-Lucent Healthcare and Life Science Symposium
which was also held this week in Las Vegas. The Agreement with
VisiInc, valued at a minimum of $17 million dollars, calls for
selling MMRPro with other Visi products collectively being sold as
VISI MMRPro through resellers of medical products and services to
healthcare professionals. The VISI MMRPro systems are part of a
Visi/MMR/Via3 product bundle being sold through a syndicate of VARs.
A copy of the signed Agreement is included in the Company's most
recent filing with the SEC.  
The VISI MMRPro system is also being sold to dentists through a major
wholesaler of dental products and services, which has an estimated
24,000 dental office clients. Visi and the wholesaler have already
begun the process of installing VISI MMRPro systems in several of its
dental clients' offices. The Visi offering also includes external
storage drives, which when connected to the VISI MMRPro system will
store documents and images created in the VISI MMRPro system in the
storage drives, as well as in MMRPro.  
About MMRGlobal, Inc.  
MMRGlobal, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR") (, provides
secure and easy-to-use online Personal Health Records ("PHRs") and
electronic safe deposit box storage solutions, serving consumers,
healthcare professionals, employers, insurance companies, financial
institutions, and professional organizations and affinity groups.
MyMedicalRecords enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. The MyM
edicalRecords Personal Health
Record is built on proprietary, patented technologies to allow
documents, images and voicemail messages to be transmitted and stored
in the system using a variety of methods, including fax, phone, or
file upload without relying on any specific electronic medical record
platform to populate a user's account. The Company's professional
offering, MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients in real time through an integrated patient
portal. MMR is an Independent Software Vendor Partner with Kodak to
deliver an integrated turnkey EMR solution for healthcare
professionals. Through its merger with Favrille, Inc. in January
2009, the Company acquired intellectual property biotech assets that
include anti-CD20 antibodies and data and samples from its
FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
and its products, visit 
Forward-Looking Statements  
Statements in this press release that are not strictly historical in
nature, including but not limited to agreements with VisiInc PLC and
the VISI MMRPro system launch, and the Company's future performance,
management's expectations, beliefs, intentions, estimates or
projections, constitute "forward-looking statements." Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "offer," "development," "if,"
"negotiate," "when," "begun," "believe," "achieve," "will,"
"estimate," "expect," "could," "maintain," "plan," and "continue," or
the negative of these words. Factors that could cause or contribute
to such differences include, but are not limited to, the risk the
Company's products are not adopted or viewed favorably by the
healthcare community; risks related to the current uncertainty and
instability in financial and lending markets, including global
economic uncertainties; variations in our quarterly operating
results; product integration in physician practices, surgery centers,
hospitals and other healthcare facilities; timing and volume of sales
and installations, including VISI MMRPro; length of sales cycles and
the installation process; market acceptance of new product
introductions; ability to establish and maintain strategic
relationships; ability to identify and integrate acquisitions;
relationships with licensees; competitive product offerings and
promotions; changes in government laws and regulations and future
changes in tax legislation and initiatives in the healthcare
industry, both in the U.S. and internationally; undetected errors in
our products; possibility of interruption at our data centers; risks
related to third party vendors; risks related to obtaining and
integrating third-party licensed technology; acceptance of the
Company's marketing and promotional campaigns; risks related to a
security breach by third parties; maintaining, developing, defending
and monetizing our intellectual property rights including those
pertaining to our biotechnology assets; risks associated with
recruitment and retention of key personnel; litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the Securities and Exchange Commission. The
Company is providing this information as of the date of this release
and, except as required by law, does not undertake any obligation to
update any forward-looking statements contained in this release as a
result of new information, future events or otherwise.  
Michael Selsman
Public Communications Co.
(310) 922-7033 
Press spacebar to pause and continue. Press esc to stop.